文献速递慢性静脉疾病

膝上段与全长大隐静脉腔内激光消融术治疗静脉曲张的手术结局比较

Surgical outcomes of above-knee versus full-length endovenous laser ablation for great saphenous vein varicose veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-10-10

结果显示AK-GSV组手术时间更短、术后早期疼痛更轻、早期VCSS和AVVQ改善更显著,且术后1、3、9个月隐神经损伤发生率更低。

核心结论

  • AK-GSV腔内激光消融是安全有效的微创治疗方法,在改善静脉淤滞症状方面与FL-GSV消融疗效相当。
  • AK-GSV消融较FL-GSV消融具有手术时间短、术后疼痛轻、恢复快和神经并发症风险低的优势。

研究设计与样本

  • 按手术方式分为AK-GSV激光治疗组(n=134)和FL-GSV激光闭合治疗组(n=166)。
  • 比较两组手术时间、术后疼痛强度、一般症状改善及隐神经损伤发生率。

临床怎么用

  • 对于下肢静脉曲张患者,AK-GSV腔内激光消融可作为安全有效的微创选择,尤其适合希望缩短手术时间、减轻术后疼痛和降低隐神经损伤风险的患者。
  • 术后早期应关注隐神经损伤情况,尽管AK-GSV组发生率较低,但仍需在1、3、9个月进行随访评估。

局限性

  • 本研究为单中心回顾性研究,可能存在选择偏倚。
  • 随访时间较短,长期疗效和复发率未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study compares the surgical outcomes between endovenous laser ablation of the above-knee great saphenous vein (AK-GSV) and full-length great saphenous vein (FL-GSV) for the treatment of lower limb varicose veins. METHODS: This retrospective study analyzed clinical data from consecutive patients with lower extremity varicose veins treated at a tertiary vascular surgery center between November 2023 and December 2024. Participants were categorized into two groups based on surgical approach: the AK-GSV laser treatment group (n = 134) and the FL-GSV laser closure treatment group (n = 166). The study compared operative time, postoperative pain intensity, improvement in general symptoms, and incidence of saphenous nerve injury between the two groups. RESULTS: AK-GSV laser treatment was associated with shorter surgical duration (60.52 ± 8.26 minutes) compared with the FL- GSV laser treatment (64.01 ± 8.71 minutes; P = .000). Additionally, AK-GSV treatment was associated with milder early postoperative pain, as reflected by lower Visual Analogue Scale (VAS) scores at 1 day (2.82 ± 0.96 vs 3.14 ± 0.83; P = .002) and 3 days (1.57 ± 0.64 vs 1.77 ± 0.67; P =.01) postoperatively. The AK-GSV treatment group exhibited superior short-term outcomes, with significantly larger reductions in the Venous Clinical Severity Score (VCSS) (P = .009) and the Aberdeen Varicose Vein Questionnaire (AVVQ) score (P = .045) during the early postoperative period (within the first 1 month postoperatively) compared with the FL-GSV group. Compared with the FL-GSV treatment group, the AK-GSV group had a significantly lower incidence of saphenous nerve injury at 1 month (4.5% vs 15.7%; P = .002), 3 months (2.2% vs 8.4%; P = .021), and 9 months (0.0% vs 4.2%; P = .018). However, this intergroup difference was no longer statistically significant at 6 months (1.5% vs 5.4%; P = .072). CONCLUSIONS: AK-GSV endovenous laser ablation is a safe and effective minimally invasive treatment approach. Compared with FL-GSV ablation, this technique demonstrates comparable efficacy in improving venous stasis symptoms while offering significant advantages, including reduced operative time, decreased postoperative pain, accelerated recovery, and lower risks of neurological complications.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Lin X, Wang Z, et al. Surgical outcomes of above-knee versus full-length endovenous laser ablation for great saphenous vein varicose veins. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 41077248. doi:10.1016/j.jvsv.2025.102342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。